Health Catalyst, Inc. Stock: price and management transactions · United States · SEC (Form 4)

About Health Catalyst, Inc.

Health Catalyst, Inc. (ticker: HCAT) is a U.S.-based healthcare data and analytics company listed on the **NASDAQ** in the **United States**. Founded in **2008** by healthcare analytics industry pioneers, the company is headquartered in **Salt Lake City, Utah**. Its core mission is to help healthcare organizations turn fragmented clinical, financial, and operational data into measurable improvement. Over time, Health Catalyst has evolved from a pure analytics vendor into a broader healthcare intelligence platform provider, combining software, cloud-based data infrastructure, and professional services. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1636422/000163642226000035/hcat-20251231.htm?utm_source=openai)) The company’s business lines center on a cloud-based data platform and a suite of applications and services designed for hospitals, health systems, and other care organizations. Health Catalyst enables clients to ingest, normalize, govern, and analyze healthcare data, then apply those insights to improve quality of care, lower costs, increase revenue, and manage population health. Its offerings include data platform capabilities, analytics and performance-improvement applications, patient engagement solutions, and implementation/consulting services. This mix gives the company recurring software exposure as well as services-led customer relationships. ([healthcatalyst.com](https://www.healthcatalyst.com/who-we-are?utm_source=openai)) From a competitive standpoint, Health Catalyst is positioned as a niche specialist rather than a horizontal enterprise software vendor. Its differentiation lies in deep healthcare domain expertise, a long operating history, and a track record of thousands of improvement projects tied to validated financial and clinical outcomes. Management describes the business as a healthcare intelligence company, and that framing reflects its attempt to compete on sector-specific workflows, outcomes, and security rather than on generic BI features alone. In practice, that places Health Catalyst alongside other healthcare data and workflow players, while its domain depth can be a meaningful barrier to entry. ([healthcatalyst.com](https://www.healthcatalyst.com/who-we-are?utm_source=openai)) Key products and strategic initiatives include the **Health Catalyst Ignite** platform, patient-engagement assets such as **Twistle**, and offerings associated with **Lumeon** and **Upfront**. In 2025, the company also launched ten AI-integrated data toolkits on the **Databricks Marketplace**, highlighting a clearer emphasis on AI-enabled, modular, and cloud-native use cases. Security and compliance remain important commercial differentiators in healthcare; Health Catalyst announced HITRUST r2 certifications for multiple offerings in late 2025, reinforcing its enterprise-grade positioning. ([healthcatalyst.com](https://www.healthcatalyst.com/news/unitypoint-health-to-unlock-next-phase-of-analytics-innovation-by-activating-health-catalyst-ignite-tm?utm_source=openai)) Geographically, the business is primarily U.S.-focused, serving American healthcare organizations and related networks. Recent company highlights show continued commercialization and product development in 2025, including the Catalyst Awards program and new client/partner activity. In March 2026, Health Catalyst reported fiscal 2025 revenue of **$311.1 million** and Adjusted EBITDA of **$41.4 million**. The company also underwent governance and leadership changes in 2026, including the appointment of **Ben Albert** as CEO and board-level changes in April 2026, which investors may view as part of an ongoing strategic reset and execution focus. ([ir.healthcatalyst.com](https://ir.healthcatalyst.com/news-releases/news-release-details/health-catalyst-announces-winners-2025-catalyst-awards?utm_source=openai))